Shyeilla V Dhuria

Summary

Publications

  1. doi request reprint Intranasal delivery to the central nervous system: mechanisms and experimental considerations
    Shyeilla V Dhuria
    Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Pharm Sci 99:1654-73. 2010
  2. doi request reprint Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system
    Shyeilla V Dhuria
    Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
    J Pharmacol Exp Ther 328:312-20. 2009
  3. doi request reprint Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system
    Shyeilla V Dhuria
    Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Pharm Sci 98:2501-15. 2009

Collaborators

Detail Information

Publications3

  1. doi request reprint Intranasal delivery to the central nervous system: mechanisms and experimental considerations
    Shyeilla V Dhuria
    Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Pharm Sci 99:1654-73. 2010
    ..Significant research will be required to develop and improve current intranasal treatments and careful consideration should be given to the factors discussed in this review...
  2. doi request reprint Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system
    Shyeilla V Dhuria
    Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
    J Pharmacol Exp Ther 328:312-20. 2009
    ..5-16-fold). Vasoconstrictor nasal formulations may have particular relevance for CNS therapeutics with adverse side effects where it would be advantageous to limit systemic exposure...
  3. doi request reprint Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system
    Shyeilla V Dhuria
    Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Pharm Sci 98:2501-15. 2009
    ..Intranasal delivery rapidly targets HC to the CNS with minimal systemic exposure, most of which reaches the brain intact by mechanisms not involving distribution from the blood and/or cerebrospinal fluid...